Literature DB >> 6246009

Spontaneous immune response of bovine leukemia-virus-infected cattle against five different viral proteins.

L Deshayes, D Levy, A L Parodi, J P Levy.   

Abstract

The sera from cattle exposed to bovine leukemia virus (BLV) have been studied by the radioimmunoprecipitation assay (RIPA) of disrupted virus proteins. All sera of animals with the adult form of lymphosarcoma precipitated four different viral proteins: gp51, gp35, p24 and p12. In contrast, the sera of five animals with the juvenile or thymic forms of bovine lymphosarcoma were completely devoid of precipitating activity against BLV proteins, confirming the absence of relationship between these rare malignant diseases and BLV infection. The sera of non-leukemic cattle from areas of high risk of exposure to BLV were either negative or positive to a lower degree than the sera of lymphosarcomatous cows. When positive they precipitated gp51, p24 and p12. Only one serum precipitated gp35. The difference was probably quantitative, the sera of leukemic animals having higher levels of precipitating activity against all the viral proteins. The anti-gp51 reactivity was in most cases the strongest, whatever the origin of the serum. In the rare sera which were positive in the classical anti-gp51 radioimmunoassay (RIA) but negative in the anti-p24 RIA, an anti-p24 activity was, however, detected by the RIPA. These results suggest that BLV-infected cows regularly produce antibodies reacting with four different viral proteins including minor viral components. In three cases with no other special features a low level of activity was detected against a fifth component: p15. There was no apparent correlation, however, between the antibody response and an hypothetical protection against BLV-induced disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246009     DOI: 10.1002/ijc.2910250412

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Proviral detection and serology in bovine leukemia virus-exposed normal cattle and cattle with lymphoma.

Authors:  R M Jacobs; Z Song; H Poon; J L Heeney; J A Taylor; B Jefferson; W Vernau; V E Valli
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  Chicken antibodies: a useful tool for antigen capture ELISA to detect bovine leukaemia virus without cross-reaction with other mammalian antibodies.

Authors:  M Juliarena; S Gutierrez; C Ceriani
Journal:  Vet Res Commun       Date:  2006-12-22       Impact factor: 2.459

3.  Pathogenicity of molecularly cloned bovine leukemia virus.

Authors:  J Rovnak; A L Boyd; J W Casey; M A Gonda; W A Jensen; G L Cockerell
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development.

Authors:  S Tajima; Y Ikawa; Y Aida
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep.

Authors:  W A Jensen; J Rovnak; G L Cockerell
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

6.  Inhibition of protein kinase C results in decreased expression of bovine leukemia virus.

Authors:  W A Jensen; B J Wicks-Beard; G L Cockerell
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

Review 7.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.